DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

Early vasopressors with restricted fluids in septic shock: no difference in days alive and home, but less pulmonary oedema

ARISE FLUIDS settles less than hoped about resuscitation strategy, ED ultrasound against formal echo for right ventricular strain in PE, and the mental health of families a year after sepsis.

The edition in brief

ARISE FLUIDS, published in NEJM in June, randomised 1,000 adults presenting to Australian and New Zealand emergency departments with septic shock to restricted fluids with early vasopressors or larger fluid volumes with later vasopressors. The restricted group received about 1.1 litres less fluid in 24 hours. Days alive and out of hospital at 90 days were identical (median 76 in both; difference 0.0, 95% CI −2.7 to 2.7). Pulmonary oedema was less common with the restricted strategy (0.6% vs 5.0%). In a retrospective cohort of 194 patients with pulmonary embolism, emergency physician point-of-care ultrasound identified right ventricular dysfunction with 76.8% sensitivity and 85.9% specificity against cardiologist echocardiography, with moderate agreement (kappa 0.63) and better accuracy in moderate to severe dysfunction. In a Japanese multicentre cohort of 94 caregiver–patient pairs after ICU sepsis, mental health problems in caregivers stayed at about 42–43% from three to twelve months while patients' own symptoms eased, and were associated most strongly with the patient's mental, not physical, recovery.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free